Loading clinical trials...
Loading clinical trials...
The hypothesis for this study is that addition of a moderate dose of radiotherapy to the primary tumor and mediastinal nodes after three months of medical treatment could reduce the tumor burden, part...
Bring this clarity to your next appointment.
Keep all your medical notes and next steps in one place.
Lead Sponsor
Swedish Lung Cancer Study Group
NCT05671510 · Non Small Cell Lung Cancer
NCT03340506 · Melanoma, Non Small Cell Lung Cancer, and more
NCT07138755 · NSCLC, Sintilimab, and more
NCT07339774 · Radiotherapy-induced Oral Mucositis
NCT06066138 · Locally Advanced Alveolar Soft Part Sarcoma, Metastatic Alveolar Soft Part Sarcoma, and more
Department of Oncology, Norrlands Universitetssjukhus
Umeå, Norrland
Department of Oncology, Karolinska University Hospital
Stockholm, Stockholm County
Department of Oncology, Sahlgrenska University Hospital
Gothenburg, Västra Götaland County
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions